761 related articles for article (PubMed ID: 30359560)
1. Mosaicism in CRISPR/Cas9-mediated genome editing.
Mehravar M; Shirazi A; Nazari M; Banan M
Dev Biol; 2019 Jan; 445(2):156-162. PubMed ID: 30359560
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
Zhang X; Wang L; Liu M; Li D
Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
[TBL] [Abstract][Full Text] [Related]
3. Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing.
Hou Y; Ureña-Bailén G; Mohammadian Gol T; Gratz PG; Gratz HP; Roig-Merino A; Antony JS; Lamsfus-Calle A; Daniel-Moreno A; Handgretinger R; Mezger M
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553615
[TBL] [Abstract][Full Text] [Related]
4. Efficient genome editing in cultured cells and embryos of Debao pig and swamp buffalo using the CRISPR/Cas9 system.
Su X; Cui K; Du S; Li H; Lu F; Shi D; Liu Q
In Vitro Cell Dev Biol Anim; 2018 May; 54(5):375-383. PubMed ID: 29556895
[TBL] [Abstract][Full Text] [Related]
5. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
6. Production of genetically engineered mice with higher efficiency, lower mosaicism, and multiplexing capability using maternally expressed Cas9.
Sakurai T; Kamiyoshi A; Kawate H; Watanabe S; Sato M; Shindo T
Sci Rep; 2020 Jan; 10(1):1091. PubMed ID: 31974430
[TBL] [Abstract][Full Text] [Related]
7. Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos.
Tu Z; Yang W; Yan S; Yin A; Gao J; Liu X; Zheng Y; Zheng J; Li Z; Yang S; Li S; Guo X; Li XJ
Sci Rep; 2017 Feb; 7():42081. PubMed ID: 28155910
[TBL] [Abstract][Full Text] [Related]
8. Effects of concentration of CRISPR/Cas9 components on genetic mosaicism in cytoplasmic microinjected porcine embryos.
Tanihara F; Hirata M; Nguyen NT; LE QA; Hirano T; Otoi T
J Reprod Dev; 2019 Jun; 65(3):209-214. PubMed ID: 30726783
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos.
Hennig SL; Owen JR; Lin JC; Young AE; Ross PJ; Van Eenennaam AL; Murray JD
Sci Rep; 2020 Dec; 10(1):22309. PubMed ID: 33339870
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated genome editing in nonhuman primates.
Kang Y; Chu C; Wang F; Niu Y
Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31636095
[TBL] [Abstract][Full Text] [Related]
11. Suppression of mosaic mutation by co-delivery of CRISPR associated protein 9 and three-prime repair exonuclease 2 into porcine zygotes via electroporation.
Yamashita S; Kogasaka Y; Hiradate Y; Tanemura K; Sendai Y
J Reprod Dev; 2020 Feb; 66(1):41-48. PubMed ID: 31761839
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9 Gene Editing: From Basic Mechanisms to Improved Strategies for Enhanced Genome Engineering In Vivo.
Salsman J; Masson JY; Orthwein A; Dellaire G
Curr Gene Ther; 2017; 17(4):263-274. PubMed ID: 29173169
[TBL] [Abstract][Full Text] [Related]
14. Efficient biallelic mutation in porcine parthenotes using a CRISPR-Cas9 system.
Tao L; Yang M; Wang X; Zhang Z; Wu Z; Tian J; An L; Wang S
Biochem Biophys Res Commun; 2016 Aug; 476(4):225-229. PubMed ID: 27221047
[TBL] [Abstract][Full Text] [Related]
15. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle CF; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
[TBL] [Abstract][Full Text] [Related]
16. Recent Progress in CRISPR/Cas9 Technology.
Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 therapeutics for liver diseases.
Aravalli RN; Steer CJ
J Cell Biochem; 2018 Jun; 119(6):4265-4278. PubMed ID: 29266637
[TBL] [Abstract][Full Text] [Related]
18. Delivery of CRISPR-Cas9 into Mouse Zygotes by Electroporation.
Qin W; Wang H
Methods Mol Biol; 2019; 1874():179-190. PubMed ID: 30353514
[TBL] [Abstract][Full Text] [Related]
19. Delivery of CRISPR/Cas9 by Novel Strategies for Gene Therapy.
Wang L; Zheng W; Liu S; Li B; Jiang X
Chembiochem; 2019 Mar; 20(5):634-643. PubMed ID: 30393919
[TBL] [Abstract][Full Text] [Related]
20. High-efficiency genome editing using a dmc1 promoter-controlled CRISPR/Cas9 system in maize.
Feng C; Su H; Bai H; Wang R; Liu Y; Guo X; Liu C; Zhang J; Yuan J; Birchler JA; Han F
Plant Biotechnol J; 2018 Nov; 16(11):1848-1857. PubMed ID: 29569825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
